Stephens started coverage on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued an overweight rating and a $24.00 price objective on the stock.
Several other equities research analysts also recently weighed in on the stock. Truist Financial initiated coverage on shares of Ardent Health Partners in a research note on Monday. They set a buy rating and a $21.00 target price for the company. Citigroup began coverage on Ardent Health Partners in a research report on Monday. They set a buy rating and a $21.00 price objective for the company. Morgan Stanley initiated coverage on Ardent Health Partners in a report on Monday. They issued an overweight rating and a $27.00 target price on the stock. Royal Bank of Canada started coverage on Ardent Health Partners in a report on Monday. They set an outperform rating and a $23.00 price target for the company. Finally, SVB Leerink started coverage on shares of Ardent Health Partners in a research note on Monday. They issued an outperform rating and a $23.00 price objective on the stock. One research analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Ardent Health Partners presently has a consensus rating of Buy and a consensus target price of $21.70.
View Our Latest Research Report on Ardent Health Partners
Ardent Health Partners Stock Performance
Ardent Health Partners Company Profile
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Recommended Stories
- Five stocks we like better than Ardent Health Partners
- Stock Dividend Cuts Happen Are You Ready?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- The How and Why of Investing in Gold Stocks
- Jeff Brown’s Exegesis AI Stock Picks
- Compound Interest and Why It Matters When Investing
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.